Effect of Levodopa on Postural Motor Learning in Parkinson Disease
Completed
Conditions studied: Parkinson Disease
In brief
The primary goal of this project is to gain a better understanding of whether and how levodopa (a common anti-Parkinson disease medication) alters postural motor learning in people with Parkinson disease. A secondary goal is to assess whether motor cortical excitability, measured via Transcranial magnetic stimulation, is related to postural motor learning. Participants with Parkinson disease will complete between 50 and 100 postural perturbations (via support surface translations), ON and OFF their dopamine replacement therapy (i.e. levodopa). Adaptation of responses to these perturbations will be tracked. Participants will also undergo transcranial magnetic stimulation to capture cortical excitability of the brain (in particular the motor cortex). Cortical excitability will be correlated to adaptation of stepping (i.e. postural motor learning) ON and OFF levodopa. Investigators will also capture postural motor learning and cortical excitability in age-matched healthy adults. Investigators hypothesize that dopamine will have a negative effect on postural motor learning, and the cortical excitability will be correlated to postural motor learning.
Key facts
- Study ID
- NCT02239978
- Run by
- VA Office of Research and Development
- People needed
- 42
- Starts
- 2014-08-01
- Expected to finish
- 2016-09-01
- Last updated by the study team
- 2017-02-23
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Between 18 and 90 years of age.
- Individuals with Parkinson Disease
- Healthy adults age-matched to PD participants
- Participants with PD will be currently taking dopamine replacement (i.e. Levodopa)
You may not qualify if…
- All subjects exclusion criteria:
- Deep brain stimulation
- Recent (within 6 months) orthopedic injuries influencing standing or balance
- Inability to stand independently
- Transcranial magnetic stimulation exclusion criteria (for the subset of individuals taking part in the Transcranial Magnetic Stimulation portion of the study):
- History of epilepsy or currently taking any epileptic medication,
- History of seizures
- Family history of epilepsy or seizures
Where it is running
- Oregon Health & Science University — Portland, Oregon, United States
- VA Portland Health Care System, Portland, OR — Portland, Oregon, United States
- VA Salt Lake City Health Care System, Salt Lake City, UT — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.